Medicare Enrolled
Dr. Michael Howard, M.D.
Urology Physician · Manasquan, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Howard from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Howard?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Howard
Dr. Michael Howard is an urology physician in Manasquan, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Howard performed 10,478 Medicare services across 4,575 unique beneficiaries.
Between the years covered by Open Payments, Dr. Howard received a total of $4,734 from 55 pharmaceutical and/or device companies across 268 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Howard is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 9% volume in NJ
$4,734 industry payments
Medicare Practice Summary
Medicare Utilization ↗10,478
Medicare services
Top 9% in NJ for urology physician
4,575
Unique beneficiaries
$41
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~524 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 2,951 | $2 | $55 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,432 | $99 | $710 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
1,168 | $2 | $16 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
777 | $67 | $501 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
607 | $8 | $15 |
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
585 | $34 | $116 |
| PSA test (prostate cancer screening) | 557 | $15 | $15 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
442 | $66 | $382 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
223 | $108 | $720 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
162 | $9 | $60 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 162 | $135 | $710 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
135 | $34 | $116 |
| Nucleic acid test for multiple organisms A laboratory test that uses amplified probe techniques to detect the genetic material of multiple organisms in a sample. |
135 | $69 | $233 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
63 | $123 | $915 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
61 | $74 | $501 |
| Complicated insertion of bladder tube | 57 | $123 | $838 |
| Complicated change of bladder tube A complex surgical procedure to replace or modify a urinary diversion tube or conduit. This involves intricate manipulation of the urinary tract to ensure proper drainage and function. |
54 | $114 | $767 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
54 | $27 | $186 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
52 | $79 | $616 |
| Molecular pathology test interpretation A physician reviews and interprets the results of a molecular pathology test to provide a diagnostic report. |
50 | $39 | $102 |
| CMV nucleic acid detection test A laboratory test that uses amplified probe techniques to detect cytomegalovirus (CMV) genetic material in a sample. |
45 | $34 | $116 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
45 | $34 | $116 |
| Herpes simplex virus nucleic acid test A laboratory test that uses an amplified probe technique to detect the genetic material of the herpes simplex virus. |
45 | $34 | $116 |
| Herpes virus-6 nucleic acid test A laboratory test that uses amplified probe techniques to detect the genetic material of herpes virus-6. |
45 | $34 | $116 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
45 | $34 | $116 |
| MRSA nucleic acid detection test A laboratory test that uses amplified probe techniques to detect the genetic material of methicillin-resistant Staphylococcus aureus (MRSA) bacteria. |
45 | $34 | $116 |
| Strep A nucleic acid amplification test A laboratory test that uses nucleic acid amplification to detect the presence of Group A Streptococcus bacteria. This method identifies the genetic material of the bacteria to determine if an infection is present. |
45 | $34 | $116 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
45 | $34 | $116 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
43 | $8 | $78 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
43 | $97 | $1,409 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
42 | $24 | $799 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
31 | $473 | $4,154 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
30 | $20 | $436 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
26 | $206 | $1,343 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
25 | $142 | $2,545 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
20 | $28 | $369 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
20 | $171 | $1,083 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
20 | $3 | $15 |
| Bladder biopsy using endoscope A procedure to remove a small tissue sample from the bladder using a thin, flexible tube with a camera. The sample is then examined to check for abnormalities. |
18 | $116 | $2,271 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
18 | $331 | $2,223 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
17 | $321 | $2,136 |
| Ureteral stent insertion via cystoscopy A tube is placed into the ureter using an endoscope inserted through the bladder. |
16 | $101 | $1,760 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
11 | $125 | $1,768 |
| Laser prostate fragmentation with bleeding control This procedure uses a laser to break up prostate tissue and control bleeding through an endoscope. |
11 | $689 | $4,477 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.7% high complexity
3.3% medium
96.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,734
Total received (2018-2024)
Avg $676/year across 7 years
Top 27% in NJ for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
55
Companies
268
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,223 (89.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$511 (10.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$630
2023
$677
2022
$780
2021
$611
2020
$466
2019
$714
2018
$856
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$83
DENTSPLY IH AB
$66
Tolmar, Inc.
$64
Myriad Genetic Laboratories, Inc.
$63
ABBVIE INC.
$46
ACCORD HEALTHCARE, INC.
$39
PFIZER INC.
$38
Teleflex LLC
$37
UROGEN PHARMA, INC.
$34
180 Medical, Inc.
$30
Agiliti Surgical, Inc.
$26
Merck Sharp & Dohme LLC
$21
Sumitomo Pharma America, Inc.
$19
Dendreon Pharmaceuticals LLC
$17
Telix Pharmaceuticals
$16
Ferring Pharmaceuticals Inc.
$15
PROGENICS PHARMACEUTICALS, INC.
$15
Top 3 companies account for 33.9% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$526
Janssen Biotech, Inc.
$496
Dendreon Pharmaceuticals LLC
$375
PFIZER INC.
$334
ABBVIE INC.
$219
180 Medical, Inc.
$180
Myriad Genetic Laboratories, Inc.
$159
Coloplast Corp
$154
Medtronic USA, Inc.
$148
Tolmar, Inc.
$126
Antares Pharma, Inc.
$122
Medtronic, Inc.
$119
Merck Sharp & Dohme LLC
$113
Janssen Products, LP
$99
Sumitomo Pharma America, Inc.
$95
DENTSPLY IH Inc.
$86
Boston Scientific Corporation
$85
Bayer HealthCare Pharmaceuticals Inc.
$82
ACCORD HEALTHCARE, INC.
$75
DENTSPLY IH AB
$66
Teleflex LLC
$56
Myovant Sciences Inc.
$56
Ferring Pharmaceuticals Inc.
$55
Tepha Inc
$54
AbbVie Inc.
$53
Aytu BioScience, Inc
$51
Covidien LP
$48
Avadel Specialty Pharmaceuticals, LLC
$43
Acerus Pharmaceuticals Corporation
$42
PALETTE LIFE SCIENCES, INC.
$40
AbbVie, Inc.
$39
TOLMAR Pharmaceuticals, Inc.
$38
Allergan Inc.
$37
Foundation Medicine, Inc.
$37
UROGEN PHARMA, INC.
$34
NeoTract Inc.
$31
UroGen Pharma, Inc.
$31
Progenics Pharmaceuticals, Inc.
$29
Sun Pharmaceutical Industries Inc.
$27
Verity Pharmaceuticals Inc.
$27
Agiliti Surgical, Inc.
$26
BOSTON SCIENTIFIC CORPORATION
$25
Axonics, Inc.
$22
Biocompatibles, Inc.
$21
Hollister Incorporated
$19
Telix Pharmaceuticals
$16
Allergan, Inc.
$15
Axonics Modulation Technologies, Inc.
$15
PROGENICS PHARMACEUTICALS, INC.
$15
Clarus Therapeutics Inc.
$14
UROVANT SCIENCES INC
$14
Alnylam Pharmaceuticals Inc.
$14
Blue Earth Diagnostics Limited
$12
Endo Pharmaceuticals Inc.
$11
Janssen Pharmaceuticals, Inc
$9
Top 3 companies account for 29.5% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AMS 700 CXR RTE Kit · Androgel · Axonics r-SNM System · Axumin · BOTOX · BOTOX THERAPEUTIC · BRACANALYSIS CDX · CAMCEVI · CLENPIQ · CONTINENCE CARE · ELIGARD · ERLEADA · Erleada · FOUNDATIONONE · GEMTESA · GalaFLEX · ILLUCCIX · INTERSTIM · JATENZO · JELMYTO · KEYTRUDA · LOFRIC · LUPRON DEPOT · LithoVue · LoFric · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · OTREXUP · OXLUMO · Otrexup · PROLARIS · PROVENGE · PYLARIFY · Prolaris · REZUM · SOLESTA · SPACEOAR VUE · SPEEDICATH · Situate · Sonablate HIFU · SpeediCath · TITAN · TOVIAZ · Trelstar · UroLift · UroLift System · VESICARE · VISUAL-ICE · VaPro · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (89%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
52
Per 100K population
8.1
County median income
$122,727
Nearest hospital
OCEAN MEDICAL CENTER
3.8 mi
3.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Howard is a clinical cardiology specialist, with above-average Medicare volume (top 9% in NJ), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Howard experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Howard performed 2,951 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Howard receive payments from pharmaceutical companies?
Yes. Dr. Howard received a total of $4,734 from 55 companies across 268 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Howard's costs compare to other urology physicians in Manasquan?
Dr. Howard's average Medicare payment per service is $41. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Howard) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Manasquan
Browse urology physicians in Manasquan ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NJ
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NJ
Which NJ urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology